Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01563419
Other study ID # magnifier
Secondary ID
Status Completed
Phase N/A
First received March 20, 2012
Last updated March 26, 2012
Start date October 2011
Est. completion date January 2012

Study information

Verified date March 2012
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority South Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Insulin treatment is crucial for glucose control. Many patients with type 2 diabetes exhibit inadequate glycemic control in spite of combination of oral antidiabetic drugs and eventually need insulin therapy. Patients who need insulin therapy are older and have poor visual acuity, which predispose to inaccurate dosing and consequent hyper or hypoglycemia.In this study, the investigators examined the clinical usefulness of a magnifier for elderly diabetic patients who had used insulin pens.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 2012
Est. primary completion date January 2012
Accepts healthy volunteers No
Gender Both
Age group 60 Years and older
Eligibility Inclusion Criteria:

- clinical diagnosis of diabetes mellitus

- over 60 years old

- who have self-injected insulin with insulin pens

Exclusion Criteria:

- who have visual acuity less than 20/200 for each eye

- who had surgery on his/her eyes within a week

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Indicator magnifying window (Izumi Planning Co.)
IZUMI PLANNING CO,.LTD.Tokyo.Japan Material: Polypropylene with polycarbonate lens

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary the time spent to complete dialing up insulin pens The investigators ask participants to dial up the random dose of insulin pens between 30 and 40 and measured the time spent to complete dialing up. from to start dialing up the selected dose to to complete dialing up, assessed up to 10 minutes No
Secondary the dosing accuracy The investigators ask participants to dial up the random dose of insulin pens between 30 and 40 and check whether they dial up the selected dose correctly. from to start dialing up the selected dose to to complete dialing up, assessed up to 10 minutes No
Secondary the convenience in using insulin pens By structured questionnaires, the investigators ask participants about the convenience in dialing up to correct doses of insulin pens. the duration of to complete filling up the questionnaires, an expected average of 10 minutes No
Secondary the self-confidence in using insulin pens By structured questionnaires, the investigators ask participants about the self-confidence in dialing up to correct doses of insulin pens the duration of to complete filling up the questionnaires, an expected average of 10 minutes No
Secondary the need for glasses in using insulin pens By structured questionnaires, the investigators ask participants about the need for glasses in dialing up to correct doses of insulin pens the duration of to complete filling up the questionnaires, an expected average of 10 minutes No
Secondary the preferences for the use of a magnifier By structured questionnaires, the investigators ask participants whether they prefer the use of a magnifier the duration of to complete filling up the questionnaires, an expected average of 10 minutes No
Secondary the recommendation for the use of a magnifier By structured questionnaires, the investigators ask participants whether they recommend the use of a magnifier to others. the duration of to complete filling up the questionnaires, an expected average of 10 minutes No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A